Medical Care
Global Cancer Screening Tests Market Research Report 2025
- Jul 08, 25
- ID: 348925
- Pages: 93
- Figures: 96
- Views: 19
The global market for Cancer Screening Tests was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Cancer Screening Tests is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cancer Screening Tests is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cancer Screening Tests in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cancer Screening Tests include Hologic, Siemens, GRAIL, Carestream Health, Philips, Shimadzu, Canon Medical Systems, Hitachi, Esaote, Agilent Technologies, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Screening Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Screening Tests.
The Cancer Screening Tests market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Screening Tests market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Screening Tests companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hologic
Siemens
GRAIL
Carestream Health
Philips
Shimadzu
Canon Medical Systems
Hitachi
Esaote
Agilent Technologies
Abbott
Beckman Coulter
QIAGEN
R-Biopharm
Sysmex
Thrive Early Early Detection
Guardant Health
Segment by Type
Physical Exam
Imaging Tests
Genetic Tests
Other
Segment by Application
Hospital
Clinic
Lab
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Screening Tests company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Cancer Screening Tests is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cancer Screening Tests is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cancer Screening Tests in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cancer Screening Tests include Hologic, Siemens, GRAIL, Carestream Health, Philips, Shimadzu, Canon Medical Systems, Hitachi, Esaote, Agilent Technologies, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Screening Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Screening Tests.
The Cancer Screening Tests market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Screening Tests market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Screening Tests companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hologic
Siemens
GRAIL
Carestream Health
Philips
Shimadzu
Canon Medical Systems
Hitachi
Esaote
Agilent Technologies
Abbott
Beckman Coulter
QIAGEN
R-Biopharm
Sysmex
Thrive Early Early Detection
Guardant Health
Segment by Type
Physical Exam
Imaging Tests
Genetic Tests
Other
Segment by Application
Hospital
Clinic
Lab
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Screening Tests company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Screening Tests Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Physical Exam
1.2.3 Imaging Tests
1.2.4 Genetic Tests
1.2.5 Other
1.3 Market by Application
1.3.1 Global Cancer Screening Tests Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Lab
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Screening Tests Market Perspective (2020-2031)
2.2 Global Cancer Screening Tests Growth Trends by Region
2.2.1 Global Cancer Screening Tests Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Screening Tests Historic Market Size by Region (2020-2025)
2.2.3 Cancer Screening Tests Forecasted Market Size by Region (2026-2031)
2.3 Cancer Screening Tests Market Dynamics
2.3.1 Cancer Screening Tests Industry Trends
2.3.2 Cancer Screening Tests Market Drivers
2.3.3 Cancer Screening Tests Market Challenges
2.3.4 Cancer Screening Tests Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Screening Tests Players by Revenue
3.1.1 Global Top Cancer Screening Tests Players by Revenue (2020-2025)
3.1.2 Global Cancer Screening Tests Revenue Market Share by Players (2020-2025)
3.2 Global Cancer Screening Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Screening Tests Revenue
3.4 Global Cancer Screening Tests Market Concentration Ratio
3.4.1 Global Cancer Screening Tests Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Screening Tests Revenue in 2024
3.5 Global Key Players of Cancer Screening Tests Head office and Area Served
3.6 Global Key Players of Cancer Screening Tests, Product and Application
3.7 Global Key Players of Cancer Screening Tests, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Screening Tests Breakdown Data by Type
4.1 Global Cancer Screening Tests Historic Market Size by Type (2020-2025)
4.2 Global Cancer Screening Tests Forecasted Market Size by Type (2026-2031)
5 Cancer Screening Tests Breakdown Data by Application
5.1 Global Cancer Screening Tests Historic Market Size by Application (2020-2025)
5.2 Global Cancer Screening Tests Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Screening Tests Market Size (2020-2031)
6.2 North America Cancer Screening Tests Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Screening Tests Market Size by Country (2020-2025)
6.4 North America Cancer Screening Tests Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Screening Tests Market Size (2020-2031)
7.2 Europe Cancer Screening Tests Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Screening Tests Market Size by Country (2020-2025)
7.4 Europe Cancer Screening Tests Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Screening Tests Market Size (2020-2031)
8.2 Asia-Pacific Cancer Screening Tests Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Screening Tests Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Screening Tests Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Screening Tests Market Size (2020-2031)
9.2 Latin America Cancer Screening Tests Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Screening Tests Market Size by Country (2020-2025)
9.4 Latin America Cancer Screening Tests Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Screening Tests Market Size (2020-2031)
10.2 Middle East & Africa Cancer Screening Tests Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Screening Tests Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Screening Tests Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Hologic
11.1.1 Hologic Company Details
11.1.2 Hologic Business Overview
11.1.3 Hologic Cancer Screening Tests Introduction
11.1.4 Hologic Revenue in Cancer Screening Tests Business (2020-2025)
11.1.5 Hologic Recent Development
11.2 Siemens
11.2.1 Siemens Company Details
11.2.2 Siemens Business Overview
11.2.3 Siemens Cancer Screening Tests Introduction
11.2.4 Siemens Revenue in Cancer Screening Tests Business (2020-2025)
11.2.5 Siemens Recent Development
11.3 GRAIL
11.3.1 GRAIL Company Details
11.3.2 GRAIL Business Overview
11.3.3 GRAIL Cancer Screening Tests Introduction
11.3.4 GRAIL Revenue in Cancer Screening Tests Business (2020-2025)
11.3.5 GRAIL Recent Development
11.4 Carestream Health
11.4.1 Carestream Health Company Details
11.4.2 Carestream Health Business Overview
11.4.3 Carestream Health Cancer Screening Tests Introduction
11.4.4 Carestream Health Revenue in Cancer Screening Tests Business (2020-2025)
11.4.5 Carestream Health Recent Development
11.5 Philips
11.5.1 Philips Company Details
11.5.2 Philips Business Overview
11.5.3 Philips Cancer Screening Tests Introduction
11.5.4 Philips Revenue in Cancer Screening Tests Business (2020-2025)
11.5.5 Philips Recent Development
11.6 Shimadzu
11.6.1 Shimadzu Company Details
11.6.2 Shimadzu Business Overview
11.6.3 Shimadzu Cancer Screening Tests Introduction
11.6.4 Shimadzu Revenue in Cancer Screening Tests Business (2020-2025)
11.6.5 Shimadzu Recent Development
11.7 Canon Medical Systems
11.7.1 Canon Medical Systems Company Details
11.7.2 Canon Medical Systems Business Overview
11.7.3 Canon Medical Systems Cancer Screening Tests Introduction
11.7.4 Canon Medical Systems Revenue in Cancer Screening Tests Business (2020-2025)
11.7.5 Canon Medical Systems Recent Development
11.8 Hitachi
11.8.1 Hitachi Company Details
11.8.2 Hitachi Business Overview
11.8.3 Hitachi Cancer Screening Tests Introduction
11.8.4 Hitachi Revenue in Cancer Screening Tests Business (2020-2025)
11.8.5 Hitachi Recent Development
11.9 Esaote
11.9.1 Esaote Company Details
11.9.2 Esaote Business Overview
11.9.3 Esaote Cancer Screening Tests Introduction
11.9.4 Esaote Revenue in Cancer Screening Tests Business (2020-2025)
11.9.5 Esaote Recent Development
11.10 Agilent Technologies
11.10.1 Agilent Technologies Company Details
11.10.2 Agilent Technologies Business Overview
11.10.3 Agilent Technologies Cancer Screening Tests Introduction
11.10.4 Agilent Technologies Revenue in Cancer Screening Tests Business (2020-2025)
11.10.5 Agilent Technologies Recent Development
11.11 Abbott
11.11.1 Abbott Company Details
11.11.2 Abbott Business Overview
11.11.3 Abbott Cancer Screening Tests Introduction
11.11.4 Abbott Revenue in Cancer Screening Tests Business (2020-2025)
11.11.5 Abbott Recent Development
11.12 Beckman Coulter
11.12.1 Beckman Coulter Company Details
11.12.2 Beckman Coulter Business Overview
11.12.3 Beckman Coulter Cancer Screening Tests Introduction
11.12.4 Beckman Coulter Revenue in Cancer Screening Tests Business (2020-2025)
11.12.5 Beckman Coulter Recent Development
11.13 QIAGEN
11.13.1 QIAGEN Company Details
11.13.2 QIAGEN Business Overview
11.13.3 QIAGEN Cancer Screening Tests Introduction
11.13.4 QIAGEN Revenue in Cancer Screening Tests Business (2020-2025)
11.13.5 QIAGEN Recent Development
11.14 R-Biopharm
11.14.1 R-Biopharm Company Details
11.14.2 R-Biopharm Business Overview
11.14.3 R-Biopharm Cancer Screening Tests Introduction
11.14.4 R-Biopharm Revenue in Cancer Screening Tests Business (2020-2025)
11.14.5 R-Biopharm Recent Development
11.15 Sysmex
11.15.1 Sysmex Company Details
11.15.2 Sysmex Business Overview
11.15.3 Sysmex Cancer Screening Tests Introduction
11.15.4 Sysmex Revenue in Cancer Screening Tests Business (2020-2025)
11.15.5 Sysmex Recent Development
11.16 Thrive Early Early Detection
11.16.1 Thrive Early Early Detection Company Details
11.16.2 Thrive Early Early Detection Business Overview
11.16.3 Thrive Early Early Detection Cancer Screening Tests Introduction
11.16.4 Thrive Early Early Detection Revenue in Cancer Screening Tests Business (2020-2025)
11.16.5 Thrive Early Early Detection Recent Development
11.17 Guardant Health
11.17.1 Guardant Health Company Details
11.17.2 Guardant Health Business Overview
11.17.3 Guardant Health Cancer Screening Tests Introduction
11.17.4 Guardant Health Revenue in Cancer Screening Tests Business (2020-2025)
11.17.5 Guardant Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Screening Tests Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Physical Exam
1.2.3 Imaging Tests
1.2.4 Genetic Tests
1.2.5 Other
1.3 Market by Application
1.3.1 Global Cancer Screening Tests Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Lab
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Screening Tests Market Perspective (2020-2031)
2.2 Global Cancer Screening Tests Growth Trends by Region
2.2.1 Global Cancer Screening Tests Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Screening Tests Historic Market Size by Region (2020-2025)
2.2.3 Cancer Screening Tests Forecasted Market Size by Region (2026-2031)
2.3 Cancer Screening Tests Market Dynamics
2.3.1 Cancer Screening Tests Industry Trends
2.3.2 Cancer Screening Tests Market Drivers
2.3.3 Cancer Screening Tests Market Challenges
2.3.4 Cancer Screening Tests Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Screening Tests Players by Revenue
3.1.1 Global Top Cancer Screening Tests Players by Revenue (2020-2025)
3.1.2 Global Cancer Screening Tests Revenue Market Share by Players (2020-2025)
3.2 Global Cancer Screening Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Screening Tests Revenue
3.4 Global Cancer Screening Tests Market Concentration Ratio
3.4.1 Global Cancer Screening Tests Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Screening Tests Revenue in 2024
3.5 Global Key Players of Cancer Screening Tests Head office and Area Served
3.6 Global Key Players of Cancer Screening Tests, Product and Application
3.7 Global Key Players of Cancer Screening Tests, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Screening Tests Breakdown Data by Type
4.1 Global Cancer Screening Tests Historic Market Size by Type (2020-2025)
4.2 Global Cancer Screening Tests Forecasted Market Size by Type (2026-2031)
5 Cancer Screening Tests Breakdown Data by Application
5.1 Global Cancer Screening Tests Historic Market Size by Application (2020-2025)
5.2 Global Cancer Screening Tests Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Screening Tests Market Size (2020-2031)
6.2 North America Cancer Screening Tests Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Screening Tests Market Size by Country (2020-2025)
6.4 North America Cancer Screening Tests Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Screening Tests Market Size (2020-2031)
7.2 Europe Cancer Screening Tests Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Screening Tests Market Size by Country (2020-2025)
7.4 Europe Cancer Screening Tests Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Screening Tests Market Size (2020-2031)
8.2 Asia-Pacific Cancer Screening Tests Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Screening Tests Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Screening Tests Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Screening Tests Market Size (2020-2031)
9.2 Latin America Cancer Screening Tests Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Screening Tests Market Size by Country (2020-2025)
9.4 Latin America Cancer Screening Tests Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Screening Tests Market Size (2020-2031)
10.2 Middle East & Africa Cancer Screening Tests Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Screening Tests Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Screening Tests Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Hologic
11.1.1 Hologic Company Details
11.1.2 Hologic Business Overview
11.1.3 Hologic Cancer Screening Tests Introduction
11.1.4 Hologic Revenue in Cancer Screening Tests Business (2020-2025)
11.1.5 Hologic Recent Development
11.2 Siemens
11.2.1 Siemens Company Details
11.2.2 Siemens Business Overview
11.2.3 Siemens Cancer Screening Tests Introduction
11.2.4 Siemens Revenue in Cancer Screening Tests Business (2020-2025)
11.2.5 Siemens Recent Development
11.3 GRAIL
11.3.1 GRAIL Company Details
11.3.2 GRAIL Business Overview
11.3.3 GRAIL Cancer Screening Tests Introduction
11.3.4 GRAIL Revenue in Cancer Screening Tests Business (2020-2025)
11.3.5 GRAIL Recent Development
11.4 Carestream Health
11.4.1 Carestream Health Company Details
11.4.2 Carestream Health Business Overview
11.4.3 Carestream Health Cancer Screening Tests Introduction
11.4.4 Carestream Health Revenue in Cancer Screening Tests Business (2020-2025)
11.4.5 Carestream Health Recent Development
11.5 Philips
11.5.1 Philips Company Details
11.5.2 Philips Business Overview
11.5.3 Philips Cancer Screening Tests Introduction
11.5.4 Philips Revenue in Cancer Screening Tests Business (2020-2025)
11.5.5 Philips Recent Development
11.6 Shimadzu
11.6.1 Shimadzu Company Details
11.6.2 Shimadzu Business Overview
11.6.3 Shimadzu Cancer Screening Tests Introduction
11.6.4 Shimadzu Revenue in Cancer Screening Tests Business (2020-2025)
11.6.5 Shimadzu Recent Development
11.7 Canon Medical Systems
11.7.1 Canon Medical Systems Company Details
11.7.2 Canon Medical Systems Business Overview
11.7.3 Canon Medical Systems Cancer Screening Tests Introduction
11.7.4 Canon Medical Systems Revenue in Cancer Screening Tests Business (2020-2025)
11.7.5 Canon Medical Systems Recent Development
11.8 Hitachi
11.8.1 Hitachi Company Details
11.8.2 Hitachi Business Overview
11.8.3 Hitachi Cancer Screening Tests Introduction
11.8.4 Hitachi Revenue in Cancer Screening Tests Business (2020-2025)
11.8.5 Hitachi Recent Development
11.9 Esaote
11.9.1 Esaote Company Details
11.9.2 Esaote Business Overview
11.9.3 Esaote Cancer Screening Tests Introduction
11.9.4 Esaote Revenue in Cancer Screening Tests Business (2020-2025)
11.9.5 Esaote Recent Development
11.10 Agilent Technologies
11.10.1 Agilent Technologies Company Details
11.10.2 Agilent Technologies Business Overview
11.10.3 Agilent Technologies Cancer Screening Tests Introduction
11.10.4 Agilent Technologies Revenue in Cancer Screening Tests Business (2020-2025)
11.10.5 Agilent Technologies Recent Development
11.11 Abbott
11.11.1 Abbott Company Details
11.11.2 Abbott Business Overview
11.11.3 Abbott Cancer Screening Tests Introduction
11.11.4 Abbott Revenue in Cancer Screening Tests Business (2020-2025)
11.11.5 Abbott Recent Development
11.12 Beckman Coulter
11.12.1 Beckman Coulter Company Details
11.12.2 Beckman Coulter Business Overview
11.12.3 Beckman Coulter Cancer Screening Tests Introduction
11.12.4 Beckman Coulter Revenue in Cancer Screening Tests Business (2020-2025)
11.12.5 Beckman Coulter Recent Development
11.13 QIAGEN
11.13.1 QIAGEN Company Details
11.13.2 QIAGEN Business Overview
11.13.3 QIAGEN Cancer Screening Tests Introduction
11.13.4 QIAGEN Revenue in Cancer Screening Tests Business (2020-2025)
11.13.5 QIAGEN Recent Development
11.14 R-Biopharm
11.14.1 R-Biopharm Company Details
11.14.2 R-Biopharm Business Overview
11.14.3 R-Biopharm Cancer Screening Tests Introduction
11.14.4 R-Biopharm Revenue in Cancer Screening Tests Business (2020-2025)
11.14.5 R-Biopharm Recent Development
11.15 Sysmex
11.15.1 Sysmex Company Details
11.15.2 Sysmex Business Overview
11.15.3 Sysmex Cancer Screening Tests Introduction
11.15.4 Sysmex Revenue in Cancer Screening Tests Business (2020-2025)
11.15.5 Sysmex Recent Development
11.16 Thrive Early Early Detection
11.16.1 Thrive Early Early Detection Company Details
11.16.2 Thrive Early Early Detection Business Overview
11.16.3 Thrive Early Early Detection Cancer Screening Tests Introduction
11.16.4 Thrive Early Early Detection Revenue in Cancer Screening Tests Business (2020-2025)
11.16.5 Thrive Early Early Detection Recent Development
11.17 Guardant Health
11.17.1 Guardant Health Company Details
11.17.2 Guardant Health Business Overview
11.17.3 Guardant Health Cancer Screening Tests Introduction
11.17.4 Guardant Health Revenue in Cancer Screening Tests Business (2020-2025)
11.17.5 Guardant Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cancer Screening Tests Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Physical Exam
Table 3. Key Players of Imaging Tests
Table 4. Key Players of Genetic Tests
Table 5. Key Players of Other
Table 6. Global Cancer Screening Tests Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Cancer Screening Tests Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Cancer Screening Tests Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Cancer Screening Tests Market Share by Region (2020-2025)
Table 10. Global Cancer Screening Tests Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Cancer Screening Tests Market Share by Region (2026-2031)
Table 12. Cancer Screening Tests Market Trends
Table 13. Cancer Screening Tests Market Drivers
Table 14. Cancer Screening Tests Market Challenges
Table 15. Cancer Screening Tests Market Restraints
Table 16. Global Cancer Screening Tests Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Cancer Screening Tests Market Share by Players (2020-2025)
Table 18. Global Top Cancer Screening Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Screening Tests as of 2024)
Table 19. Ranking of Global Top Cancer Screening Tests Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Cancer Screening Tests Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Cancer Screening Tests, Headquarters and Area Served
Table 22. Global Key Players of Cancer Screening Tests, Product and Application
Table 23. Global Key Players of Cancer Screening Tests, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cancer Screening Tests Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Cancer Screening Tests Revenue Market Share by Type (2020-2025)
Table 27. Global Cancer Screening Tests Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Cancer Screening Tests Revenue Market Share by Type (2026-2031)
Table 29. Global Cancer Screening Tests Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Cancer Screening Tests Revenue Market Share by Application (2020-2025)
Table 31. Global Cancer Screening Tests Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Cancer Screening Tests Revenue Market Share by Application (2026-2031)
Table 33. North America Cancer Screening Tests Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Cancer Screening Tests Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Cancer Screening Tests Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Cancer Screening Tests Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Cancer Screening Tests Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Cancer Screening Tests Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Cancer Screening Tests Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Cancer Screening Tests Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Cancer Screening Tests Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Cancer Screening Tests Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Cancer Screening Tests Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Cancer Screening Tests Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Cancer Screening Tests Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Cancer Screening Tests Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Cancer Screening Tests Market Size by Country (2026-2031) & (US$ Million)
Table 48. Hologic Company Details
Table 49. Hologic Business Overview
Table 50. Hologic Cancer Screening Tests Product
Table 51. Hologic Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 52. Hologic Recent Development
Table 53. Siemens Company Details
Table 54. Siemens Business Overview
Table 55. Siemens Cancer Screening Tests Product
Table 56. Siemens Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 57. Siemens Recent Development
Table 58. GRAIL Company Details
Table 59. GRAIL Business Overview
Table 60. GRAIL Cancer Screening Tests Product
Table 61. GRAIL Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 62. GRAIL Recent Development
Table 63. Carestream Health Company Details
Table 64. Carestream Health Business Overview
Table 65. Carestream Health Cancer Screening Tests Product
Table 66. Carestream Health Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 67. Carestream Health Recent Development
Table 68. Philips Company Details
Table 69. Philips Business Overview
Table 70. Philips Cancer Screening Tests Product
Table 71. Philips Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 72. Philips Recent Development
Table 73. Shimadzu Company Details
Table 74. Shimadzu Business Overview
Table 75. Shimadzu Cancer Screening Tests Product
Table 76. Shimadzu Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 77. Shimadzu Recent Development
Table 78. Canon Medical Systems Company Details
Table 79. Canon Medical Systems Business Overview
Table 80. Canon Medical Systems Cancer Screening Tests Product
Table 81. Canon Medical Systems Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 82. Canon Medical Systems Recent Development
Table 83. Hitachi Company Details
Table 84. Hitachi Business Overview
Table 85. Hitachi Cancer Screening Tests Product
Table 86. Hitachi Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 87. Hitachi Recent Development
Table 88. Esaote Company Details
Table 89. Esaote Business Overview
Table 90. Esaote Cancer Screening Tests Product
Table 91. Esaote Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 92. Esaote Recent Development
Table 93. Agilent Technologies Company Details
Table 94. Agilent Technologies Business Overview
Table 95. Agilent Technologies Cancer Screening Tests Product
Table 96. Agilent Technologies Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 97. Agilent Technologies Recent Development
Table 98. Abbott Company Details
Table 99. Abbott Business Overview
Table 100. Abbott Cancer Screening Tests Product
Table 101. Abbott Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 102. Abbott Recent Development
Table 103. Beckman Coulter Company Details
Table 104. Beckman Coulter Business Overview
Table 105. Beckman Coulter Cancer Screening Tests Product
Table 106. Beckman Coulter Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 107. Beckman Coulter Recent Development
Table 108. QIAGEN Company Details
Table 109. QIAGEN Business Overview
Table 110. QIAGEN Cancer Screening Tests Product
Table 111. QIAGEN Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 112. QIAGEN Recent Development
Table 113. R-Biopharm Company Details
Table 114. R-Biopharm Business Overview
Table 115. R-Biopharm Cancer Screening Tests Product
Table 116. R-Biopharm Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 117. R-Biopharm Recent Development
Table 118. Sysmex Company Details
Table 119. Sysmex Business Overview
Table 120. Sysmex Cancer Screening Tests Product
Table 121. Sysmex Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 122. Sysmex Recent Development
Table 123. Thrive Early Early Detection Company Details
Table 124. Thrive Early Early Detection Business Overview
Table 125. Thrive Early Early Detection Cancer Screening Tests Product
Table 126. Thrive Early Early Detection Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 127. Thrive Early Early Detection Recent Development
Table 128. Guardant Health Company Details
Table 129. Guardant Health Business Overview
Table 130. Guardant Health Cancer Screening Tests Product
Table 131. Guardant Health Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 132. Guardant Health Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Cancer Screening Tests Picture
Figure 2. Global Cancer Screening Tests Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cancer Screening Tests Market Share by Type: 2024 VS 2031
Figure 4. Physical Exam Features
Figure 5. Imaging Tests Features
Figure 6. Genetic Tests Features
Figure 7. Other Features
Figure 8. Global Cancer Screening Tests Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Cancer Screening Tests Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Lab Case Studies
Figure 13. Other Case Studies
Figure 14. Cancer Screening Tests Report Years Considered
Figure 15. Global Cancer Screening Tests Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Cancer Screening Tests Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Cancer Screening Tests Market Share by Region: 2024 VS 2031
Figure 18. Global Cancer Screening Tests Market Share by Players in 2024
Figure 19. Global Top Cancer Screening Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Screening Tests as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Cancer Screening Tests Revenue in 2024
Figure 21. North America Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Cancer Screening Tests Market Share by Country (2020-2031)
Figure 23. United States Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Cancer Screening Tests Market Share by Country (2020-2031)
Figure 27. Germany Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Cancer Screening Tests Market Share by Region (2020-2031)
Figure 35. China Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Cancer Screening Tests Market Share by Country (2020-2031)
Figure 43. Mexico Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Cancer Screening Tests Market Share by Country (2020-2031)
Figure 47. Turkey Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Hologic Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 51. Siemens Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 52. GRAIL Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 53. Carestream Health Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 54. Philips Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 55. Shimadzu Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 56. Canon Medical Systems Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 57. Hitachi Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 58. Esaote Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 59. Agilent Technologies Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 60. Abbott Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 61. Beckman Coulter Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 62. QIAGEN Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 63. R-Biopharm Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 64. Sysmex Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 65. Thrive Early Early Detection Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 66. Guardant Health Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Table 1. Global Cancer Screening Tests Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Physical Exam
Table 3. Key Players of Imaging Tests
Table 4. Key Players of Genetic Tests
Table 5. Key Players of Other
Table 6. Global Cancer Screening Tests Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Cancer Screening Tests Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Cancer Screening Tests Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Cancer Screening Tests Market Share by Region (2020-2025)
Table 10. Global Cancer Screening Tests Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Cancer Screening Tests Market Share by Region (2026-2031)
Table 12. Cancer Screening Tests Market Trends
Table 13. Cancer Screening Tests Market Drivers
Table 14. Cancer Screening Tests Market Challenges
Table 15. Cancer Screening Tests Market Restraints
Table 16. Global Cancer Screening Tests Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Cancer Screening Tests Market Share by Players (2020-2025)
Table 18. Global Top Cancer Screening Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Screening Tests as of 2024)
Table 19. Ranking of Global Top Cancer Screening Tests Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Cancer Screening Tests Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Cancer Screening Tests, Headquarters and Area Served
Table 22. Global Key Players of Cancer Screening Tests, Product and Application
Table 23. Global Key Players of Cancer Screening Tests, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cancer Screening Tests Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Cancer Screening Tests Revenue Market Share by Type (2020-2025)
Table 27. Global Cancer Screening Tests Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Cancer Screening Tests Revenue Market Share by Type (2026-2031)
Table 29. Global Cancer Screening Tests Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Cancer Screening Tests Revenue Market Share by Application (2020-2025)
Table 31. Global Cancer Screening Tests Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Cancer Screening Tests Revenue Market Share by Application (2026-2031)
Table 33. North America Cancer Screening Tests Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Cancer Screening Tests Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Cancer Screening Tests Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Cancer Screening Tests Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Cancer Screening Tests Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Cancer Screening Tests Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Cancer Screening Tests Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Cancer Screening Tests Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Cancer Screening Tests Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Cancer Screening Tests Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Cancer Screening Tests Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Cancer Screening Tests Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Cancer Screening Tests Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Cancer Screening Tests Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Cancer Screening Tests Market Size by Country (2026-2031) & (US$ Million)
Table 48. Hologic Company Details
Table 49. Hologic Business Overview
Table 50. Hologic Cancer Screening Tests Product
Table 51. Hologic Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 52. Hologic Recent Development
Table 53. Siemens Company Details
Table 54. Siemens Business Overview
Table 55. Siemens Cancer Screening Tests Product
Table 56. Siemens Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 57. Siemens Recent Development
Table 58. GRAIL Company Details
Table 59. GRAIL Business Overview
Table 60. GRAIL Cancer Screening Tests Product
Table 61. GRAIL Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 62. GRAIL Recent Development
Table 63. Carestream Health Company Details
Table 64. Carestream Health Business Overview
Table 65. Carestream Health Cancer Screening Tests Product
Table 66. Carestream Health Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 67. Carestream Health Recent Development
Table 68. Philips Company Details
Table 69. Philips Business Overview
Table 70. Philips Cancer Screening Tests Product
Table 71. Philips Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 72. Philips Recent Development
Table 73. Shimadzu Company Details
Table 74. Shimadzu Business Overview
Table 75. Shimadzu Cancer Screening Tests Product
Table 76. Shimadzu Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 77. Shimadzu Recent Development
Table 78. Canon Medical Systems Company Details
Table 79. Canon Medical Systems Business Overview
Table 80. Canon Medical Systems Cancer Screening Tests Product
Table 81. Canon Medical Systems Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 82. Canon Medical Systems Recent Development
Table 83. Hitachi Company Details
Table 84. Hitachi Business Overview
Table 85. Hitachi Cancer Screening Tests Product
Table 86. Hitachi Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 87. Hitachi Recent Development
Table 88. Esaote Company Details
Table 89. Esaote Business Overview
Table 90. Esaote Cancer Screening Tests Product
Table 91. Esaote Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 92. Esaote Recent Development
Table 93. Agilent Technologies Company Details
Table 94. Agilent Technologies Business Overview
Table 95. Agilent Technologies Cancer Screening Tests Product
Table 96. Agilent Technologies Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 97. Agilent Technologies Recent Development
Table 98. Abbott Company Details
Table 99. Abbott Business Overview
Table 100. Abbott Cancer Screening Tests Product
Table 101. Abbott Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 102. Abbott Recent Development
Table 103. Beckman Coulter Company Details
Table 104. Beckman Coulter Business Overview
Table 105. Beckman Coulter Cancer Screening Tests Product
Table 106. Beckman Coulter Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 107. Beckman Coulter Recent Development
Table 108. QIAGEN Company Details
Table 109. QIAGEN Business Overview
Table 110. QIAGEN Cancer Screening Tests Product
Table 111. QIAGEN Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 112. QIAGEN Recent Development
Table 113. R-Biopharm Company Details
Table 114. R-Biopharm Business Overview
Table 115. R-Biopharm Cancer Screening Tests Product
Table 116. R-Biopharm Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 117. R-Biopharm Recent Development
Table 118. Sysmex Company Details
Table 119. Sysmex Business Overview
Table 120. Sysmex Cancer Screening Tests Product
Table 121. Sysmex Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 122. Sysmex Recent Development
Table 123. Thrive Early Early Detection Company Details
Table 124. Thrive Early Early Detection Business Overview
Table 125. Thrive Early Early Detection Cancer Screening Tests Product
Table 126. Thrive Early Early Detection Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 127. Thrive Early Early Detection Recent Development
Table 128. Guardant Health Company Details
Table 129. Guardant Health Business Overview
Table 130. Guardant Health Cancer Screening Tests Product
Table 131. Guardant Health Revenue in Cancer Screening Tests Business (2020-2025) & (US$ Million)
Table 132. Guardant Health Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Cancer Screening Tests Picture
Figure 2. Global Cancer Screening Tests Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cancer Screening Tests Market Share by Type: 2024 VS 2031
Figure 4. Physical Exam Features
Figure 5. Imaging Tests Features
Figure 6. Genetic Tests Features
Figure 7. Other Features
Figure 8. Global Cancer Screening Tests Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Cancer Screening Tests Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Lab Case Studies
Figure 13. Other Case Studies
Figure 14. Cancer Screening Tests Report Years Considered
Figure 15. Global Cancer Screening Tests Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Cancer Screening Tests Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Cancer Screening Tests Market Share by Region: 2024 VS 2031
Figure 18. Global Cancer Screening Tests Market Share by Players in 2024
Figure 19. Global Top Cancer Screening Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Screening Tests as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Cancer Screening Tests Revenue in 2024
Figure 21. North America Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Cancer Screening Tests Market Share by Country (2020-2031)
Figure 23. United States Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Cancer Screening Tests Market Share by Country (2020-2031)
Figure 27. Germany Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Cancer Screening Tests Market Share by Region (2020-2031)
Figure 35. China Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Cancer Screening Tests Market Share by Country (2020-2031)
Figure 43. Mexico Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Cancer Screening Tests Market Share by Country (2020-2031)
Figure 47. Turkey Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Cancer Screening Tests Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Hologic Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 51. Siemens Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 52. GRAIL Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 53. Carestream Health Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 54. Philips Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 55. Shimadzu Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 56. Canon Medical Systems Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 57. Hitachi Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 58. Esaote Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 59. Agilent Technologies Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 60. Abbott Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 61. Beckman Coulter Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 62. QIAGEN Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 63. R-Biopharm Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 64. Sysmex Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 65. Thrive Early Early Detection Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 66. Guardant Health Revenue Growth Rate in Cancer Screening Tests Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232